The role of biogenic amines in the reserpine-induced alteration of minimal electroshock seizure thresholds in the mouse.
D006916:5-Hydroxytryptophan / Q000494:pharmacology; D000818:Animals; D001679:Biogenic Amines / Q000037:antagonists & inhibitors / Q000096:biosynthesis / Q000378:metabolism*; D001921:Brain / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism; D004221:Disulfiram / Q000494:pharmacology; D004298:Dopamine / Q000378:metabolism; D004347:Drug Interactions; D004597:Electroshock; D005260:Female; D010134:Fenclonine / Q000494:pharmacology; D008781:Methyltyrosines / Q000494:pharmacology; D051379:Mice; D009638:Norepinephrine / Q000378:metabolism; D012110:Reserpine / Q000494:pharmacology*; D012640:Seizures / Q000378:metabolism*; D012701:Serotonin / Q000378:metabolism; D012702:Serotonin Antagonists; D013997:Time Factors; D014316:Tritium; D014443:Tyrosine / Q000494:pharmacology; D014446:Tyrosine 3-Monooxygenase / Q000037:antagonists & inhibitors
D001679:Biogenic Amines; D008781:Methyltyrosines; D012702:Serotonin Antagonists; D014316:Tritium; D012701:Serotonin; D014443:Tyrosine; D012110:Reserpine; D006916:5-Hydroxytryptophan; D014446:Tyrosine 3-Monooxygenase; D010134:Fenclonine; D004221:Disulfiram; D004298:Dopamine; D009638:Norepinephrine